Intraosseous Infusion Devices Market Synopsis:

Intraosseous Infusion Devices Market Size Was Valued at USD 4.4 Billion in 2023, and is Projected to Reach USD 8.27 Billion by 2032, Growing at a CAGR of 7.0% From 2024-2032.

Intraosseous infusion devices are therapeutic equipment used to administer fluids and medications, blood products and factors directly to the space occupied in the bone marrow whenever IV access is restricted or less feasible. These devices are particularly useful in conditions that may include cardiac arrest or trauma in that early access to vessels is essential for the survival of the patient. Because intraosseous infusion by-passes the vascular system for a short time, the agents can be delivered to the patient swiftly and effectively.

Increased incidence of trauma cases and medical emergencies is a major factor contributing to the development of intraosseous infusion devices market. More and more accidents, injuries and acute acute/critical health conditions occur around the world, therefore, the use of effective and high-speed resuscitation techniques becomes urgent. Available literatures showed that intraosseous infusion provides a effective solution in emergent cases when intravenous access could be a challenge or takes time; this location improves the patients’ results and as such, fuels buy these devices among the caregivers.

The third factor is the ongoing advancements of medical technologies within healthcare organisations. Intraosseous devices, in particular powered infusion system and new easy to use manual systems have enhanced the technique compared to traditional use. In addition, training programs of healthcare workers made intraosseous access as one of the techniques they need to master, which put those devices into frequent use in clinical practice. Hospitals and other health care organizations have been embracing sophisticated technologies in the diagnosis and treatment of illnesses, and it is against this back drop that the intraosseous infusion market will experience a significant growth.

Intraosseous Infusion Devices Market

Intraosseous Infusion Devices Market Trend Analysis:

Increasing focus on training and education for healthcare professionals.

  • A major development trend reflected in the intraosseous infusion devices market is the stronger emphasis on continuing education of healthcare practitioners. Since more and more people learn about the advantages of using intraosseous access, many healthcare facilities, as well as emergency services, launch training sessions that improve the performance of medical personnel in manipulations with these devices. As for the mass population, it’s not only helping advance the state of patient care but also leading to more heightened awareness of patients to be ready for emergency cases when intraosseous infusion might be needed.
  • In the near future, there are new tendencies in intraosseous infusion devices, for example, the development of the infusion smarts that can indicate the rates of infusion and give back the data to the providers. These innovations are meant to improve the outcomes of intraosseous interventions thereby increasing the safety of the procedures for patients. The connectivity features incorporated in the system as well as data analytics aspect also enhance better tracking of device usage and patients’ response hence boosting the growth of the market.

Healthcare infrastructure improves and more facilities adopt advanced medical technologies.

  • As discussed above, the market of intraosseous infusion devices has several prospects in the context of its growth which can be linked with the improvement of the health care accessibility and availability in the further developing countries. As more facilities are being developed and the technology of treatment is being promoted with new and highly developed medical tools, there is an opportunity to make greater usage of the intraosseous devices. There is an opportunity for these markets to consolidate with such firms aiming at spreading information on the need for intraosseous access especially during emergencies.
  • However, cooperation between manufacturers and healthcare organizations can improve the ideas and research of better intraosseous devices. The partnerships and research collaborations in such areas can resolve unique demands within the market and improve the efficacy of intraosseous infusions among patients. Apart from increasing growth within the market, this approach will promote both, health patient care and results.

Intraosseous Infusion Devices Market Segment Analysis:

Intraosseous Infusion Devices Market is Segmented on the basis of Product type, Material, application, end user, and Region

By Product Type, Manual Devices segment is expected to dominate the market during the forecast period

  • Intraosseous infusion devices can be categorized into two main product types: the following broad categories: the manual devices and the powered devices. Manual devices are operated by health care professionals via a hand crank that drives the needle into the bone Most of them are relatively less precise hence may need a health professional to accurately deploy the needle into the bone. These devices normally not bulky, easily transportable and intended for emergencies when quick reference is needed. However, powered device have motorized and battery operated systems to ease the insertion process hence provision of quick and efficient intraosseous space. Customized devices are used more frequently in emergency situations since the number of mistakes made by a user could be higher, and powered devices can increase effectiveness during crucial manipulations. Each product type has significant purposes in improving patients’ care in emergent conditions and supplying the healthcare professionals with efficient means for vascular access.

By Application, Adult segment expected to held the largest share

  • Intraosseous infusion devices are classified based on application into two main categories: adult and pediatric. The adult application is designed to be concerned with promptly gaining access to the intraosseous space for medications, fluids, and blood products in adult patients with medical emergencies, traumatic injuries or critical illness. These devices are developed with consideration of the individuals’ anatomy in the adult population to allow good and safe access to the bone marrow for different therapeutic procedures.
  • In contrast, the intraosseous infusion devices for the pediatric involves the specialty of infants and children. These devices are designed to be adapted to fit the small anatomy and physiology of children making them appropriate to be used on this susceptible group. Since children may get worse very fast in emergency conditions, constant possibility to initiate intra Os access is critical. Children IOs come with features that make their placement safe without causing much harm to the child hence being safe and effective practice for children emphasized for FLUID administration medications.

Intraosseous Infusion Devices Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • As of now, North America holds the largest market share for intraosseous infusion devices, helped again by the robust medical industry, high adaptability for new technologies, and focus on emergency operations. Adding to this, availability of key medical device players and extensive infrastructure of hospitals/medical facilities and emergency services across the region also play a key role in coronating this region as the leader. Moreover, studies are being conducted in the USA and Canada to advance practical application of intraosseous devices and make them more effective.
  • Moreover, high rates of trauma specific cases and other any medical emergencies present in North American region are testimony to the need for more efficient access procedures such as intraosseous infusion. More healthcare professionals are now taught the use of these devices, this has in turn resulted in the increased use of the device at both the pre hospital and the hospital stages. These factors together make North America occupy the position of the largest consumer of intraosseous infusion devices and is carried forward to have the similar trend in the future years.

Active Key Players in the Intraosseous Infusion Devices Market:

  • Acumen Medical (USA)
  • BD (Becton, Dickinson and Company) (USA)
  • Cook Medical (USA)
  • Laerdal Medical (Norway)
  • PEP® (Germany)
  • PerSys Medical (Israel)
  • Stille (Sweden)
  • Teleflex (USA)
  • Vygon (France)
  • ZOLL Medical Corporation (USA)
  • Other Active Players

Intraosseous Infusion Devices Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 4.5 Billion

Forecast Period 2024-32 CAGR:

 7.0%

Market Size in 2032:

USD 8.27 Billion

Segments Covered:

By Product Type

  • Manual Devices
  • Powered Devices

By Material

  • Stainless Steel
  • Plastic
  • Other Materials

By Application

  • Adult
  • Pediatric

By End User

  • Hospitals
  • Emergency Medical Services (EMS)
  • Military
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Prevalence of Trauma Cases

Key Market Restraints:

  • Limited Awareness Among Healthcare Providers

Key Opportunities:

  • Collaborative Innovation in Device Development

Companies Covered in the report:

  • Teleflex (USA), BD (Becton, Dickinson and Company) (USA), ZOLL Medical Corporation (USA), Cook Medical (USA), PerSys Medical (Israel), PEP® (Germany), Acumen Medical (USA), Stille (Sweden), Vygon (France), Laerdal Medical (Norway) and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Intraosseous Infusion Devices Market by Product Type
 4.1 Intraosseous Infusion Devices Market Snapshot and Growth Engine
 4.2 Intraosseous Infusion Devices Market Overview
 4.3 Manual Devices
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Manual Devices: Geographic Segmentation Analysis
 4.4 Powered Devices
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Powered Devices: Geographic Segmentation Analysis

Chapter 5: Intraosseous Infusion Devices Market by Material
 5.1 Intraosseous Infusion Devices Market Snapshot and Growth Engine
 5.2 Intraosseous Infusion Devices Market Overview
 5.3 Stainless Steel
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Stainless Steel: Geographic Segmentation Analysis
 5.4 Plastic
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Plastic: Geographic Segmentation Analysis
 5.5 Other Materials
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Other Materials: Geographic Segmentation Analysis

Chapter 6: Intraosseous Infusion Devices Market by Application
 6.1 Intraosseous Infusion Devices Market Snapshot and Growth Engine
 6.2 Intraosseous Infusion Devices Market Overview
 6.3 Adult
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Adult: Geographic Segmentation Analysis
 6.4 Pediatric
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Pediatric: Geographic Segmentation Analysis

Chapter 7: Intraosseous Infusion Devices Market by End User
 7.1 Intraosseous Infusion Devices Market Snapshot and Growth Engine
 7.2 Intraosseous Infusion Devices Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Emergency Medical Services (EMS)
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Emergency Medical Services (EMS): Geographic Segmentation Analysis
 7.5 Military
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Military: Geographic Segmentation Analysis
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Intraosseous Infusion Devices Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 ACUMEN MEDICAL (USA)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 BD (BECTON
 8.4 DICKINSON AND COMPANY) (USA)
 8.5 COOK MEDICAL (USA)
 8.6 LAERDAL MEDICAL (NORWAY)
 8.7 PEP® (GERMANY)
 8.8 PERSYS MEDICAL (ISRAEL)
 8.9 STILLE (SWEDEN)
 8.10 TELEFLEX (USA)
 8.11 VYGON (FRANCE)
 8.12 ZOLL MEDICAL CORPORATION (USA)
 8.13 .
 8.14 OTHER ACTIVE PLAYERS

Chapter 9: Global Intraosseous Infusion Devices Market By Region
 9.1 Overview
9.2. North America Intraosseous Infusion Devices Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Manual Devices
  9.2.4.2 Powered Devices
  9.2.5 Historic and Forecasted Market Size By Material
  9.2.5.1 Stainless Steel
  9.2.5.2 Plastic
  9.2.5.3 Other Materials
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Adult
  9.2.6.2 Pediatric
  9.2.7 Historic and Forecasted Market Size By End User
  9.2.7.1 Hospitals
  9.2.7.2 Emergency Medical Services (EMS)
  9.2.7.3 Military
  9.2.7.4 Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
9.3. Eastern Europe Intraosseous Infusion Devices Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Manual Devices
  9.3.4.2 Powered Devices
  9.3.5 Historic and Forecasted Market Size By Material
  9.3.5.1 Stainless Steel
  9.3.5.2 Plastic
  9.3.5.3 Other Materials
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Adult
  9.3.6.2 Pediatric
  9.3.7 Historic and Forecasted Market Size By End User
  9.3.7.1 Hospitals
  9.3.7.2 Emergency Medical Services (EMS)
  9.3.7.3 Military
  9.3.7.4 Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Intraosseous Infusion Devices Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Manual Devices
  9.4.4.2 Powered Devices
  9.4.5 Historic and Forecasted Market Size By Material
  9.4.5.1 Stainless Steel
  9.4.5.2 Plastic
  9.4.5.3 Other Materials
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Adult
  9.4.6.2 Pediatric
  9.4.7 Historic and Forecasted Market Size By End User
  9.4.7.1 Hospitals
  9.4.7.2 Emergency Medical Services (EMS)
  9.4.7.3 Military
  9.4.7.4 Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Intraosseous Infusion Devices Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Manual Devices
  9.5.4.2 Powered Devices
  9.5.5 Historic and Forecasted Market Size By Material
  9.5.5.1 Stainless Steel
  9.5.5.2 Plastic
  9.5.5.3 Other Materials
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Adult
  9.5.6.2 Pediatric
  9.5.7 Historic and Forecasted Market Size By End User
  9.5.7.1 Hospitals
  9.5.7.2 Emergency Medical Services (EMS)
  9.5.7.3 Military
  9.5.7.4 Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
9.6. Middle East & Africa Intraosseous Infusion Devices Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Manual Devices
  9.6.4.2 Powered Devices
  9.6.5 Historic and Forecasted Market Size By Material
  9.6.5.1 Stainless Steel
  9.6.5.2 Plastic
  9.6.5.3 Other Materials
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Adult
  9.6.6.2 Pediatric
  9.6.7 Historic and Forecasted Market Size By End User
  9.6.7.1 Hospitals
  9.6.7.2 Emergency Medical Services (EMS)
  9.6.7.3 Military
  9.6.7.4 Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
9.7. South America Intraosseous Infusion Devices Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Manual Devices
  9.7.4.2 Powered Devices
  9.7.5 Historic and Forecasted Market Size By Material
  9.7.5.1 Stainless Steel
  9.7.5.2 Plastic
  9.7.5.3 Other Materials
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Adult
  9.7.6.2 Pediatric
  9.7.7 Historic and Forecasted Market Size By End User
  9.7.7.1 Hospitals
  9.7.7.2 Emergency Medical Services (EMS)
  9.7.7.3 Military
  9.7.7.4 Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
 

Intraosseous Infusion Devices Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 4.5 Billion

Forecast Period 2024-32 CAGR:

 7.0%

Market Size in 2032:

USD 8.27 Billion

Segments Covered:

By Product Type

  • Manual Devices
  • Powered Devices

By Material

  • Stainless Steel
  • Plastic
  • Other Materials

By Application

  • Adult
  • Pediatric

By End User

  • Hospitals
  • Emergency Medical Services (EMS)
  • Military
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Prevalence of Trauma Cases

Key Market Restraints:

  • Limited Awareness Among Healthcare Providers

Key Opportunities:

  • Collaborative Innovation in Device Development

Companies Covered in the report:

  • Teleflex (USA), BD (Becton, Dickinson and Company) (USA), ZOLL Medical Corporation (USA), Cook Medical (USA), PerSys Medical (Israel), PEP® (Germany), Acumen Medical (USA), Stille (Sweden), Vygon (France), Laerdal Medical (Norway) and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the Intraosseous Infusion Devices Market research report?
The forecast period in the Intraosseous Infusion Devices Market research report is 2024-2032.
Who are the key players in the Intraosseous Infusion Devices Market?
Teleflex (USA), BD (Becton, Dickinson and Company) (USA), ZOLL Medical Corporation (USA), Cook Medical (USA), PerSys Medical (Israel), PEP® (Germany), Acumen Medical (USA), Stille (Sweden), Vygon (France), Laerdal Medical (Norway) and Other Active Players.
What are the segments of the Intraosseous Infusion Devices Market?
The Intraosseous Infusion Devices Market is segmented into by Product Type (Manual Devices, Powered Devices), By Material (Stainless Steel, Plastic, Other Materials), Application (Adult, Pediatric), End User (Hospitals, Emergency Medical Services (EMS), Military, Others). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
What is the Intraosseous Infusion Devices Market?
Intraosseous infusion devices are therapeutic equipment used to administer fluids and medications, blood products and factors directly to the space occupied in the bone marrow whenever IV access is restricted or less feasible. These devices are particularly useful in conditions that may include cardiac arrest or trauma in that early access to vessels is essential for the survival of the patient. Because intraosseous infusion by-passes the vascular system for a short time, the agents can be delivered to the patient swiftly and effectively.
How big is the Intraosseous Infusion Devices Market?
Intraosseous Infusion Devices Market Size Was Valued at USD 4.4 Billion in 2023, and is Projected to Reach USD 8.27 Billion by 2032, Growing at a CAGR of 7.0% From 2024-2032.